Au nanostructures: An emerging prospect in cancer theranostics

Science China Life Sciences

Volumn 55, Issue 10, 2012, Pages 872-883

  Nie, Xin ^a   Chen, ChunYing ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

anti tumor activity; Au nanoparticle; diagnostics; drug delivery; photothermal therapy; surface plasmon resonance

Indexed keywords

ANTINEOPLASTIC AGENT; GOLD; NANOMATERIAL;

COMPUTER ASSISTED TOMOGRAPHY; HUMAN; NEOPLASM; RADIOGRAPHY; REVIEW; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; GOLD; HUMANS; NANOSTRUCTURES; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868348645     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4389-5     Document Type: Review

References (80)

1. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 2011, 61: 212-36.
2. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer, 2005, 5: 161-71.
3. Faraday M. The Bakerian lecture: experimental relations of gold (and other metals) to light philos. Trans R Soc London, 1857, 147: 145-181.
4. Mie G. Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen. Ann Phys, 1908, 25: 377-445.
5. Knoll M, Ruska E. Das Elektronenmikroskop. Z Phys, 1932, 78: 318-339.
6. Turkevich J, Stevenson P C, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc, 1951, 11: 55-75.
7. Jiang X M, Wang L M, Wang J, et al. Gold nanomaterials: preparation, chemical modification, biomedical applications and potential risk assessment. Appl Biochem Biotech, 2012, 166: 1533-1551.
8. Shimizu T, Teranishi T, HASEGAWA S, et al. Size evolution of alkanethiol-protected gold nanoparticles by heat treatment in the solid state. J Phys Chem B, 2003, 107: 2719-2724.
9. 4OH. Nano Lett, 2007, 7: 1764-1769.
10. Liang H P, Wan L J, Bai C L, et al. Gold hollow nanospheres: tunable surface plasmon resonance controlled by interior-cavity sizes. J Phys Chem B, 2005, 109: 7795-7800.
11. Zhang J, Langille M R, Personick M L, et al. Concave cubic gold nanocrystals with high-index facets. J Am Chem Soc, 2010, 132: 14012-14014.
12. Tian M, Wei F, Qin T, et al. Growth of tetrahexahedral gold nanocrystals with high-index facets. J Am Chem Soc, 2009, 131: 16350-16351.
13. Dreaden E C, Alkilany A M, Huang X H, et al. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev, 2012, 41: 2740-2779.
14. Alkilany A M, Murphy C J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res, 2010, 12: 2313-2333.
15. Turner M, Golovko V B, Vaughan O P H, et al. Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters. Nature, 2008, 454: 981-983.
16. Alkilany A M, Nagaria P K, Hexel C R, et al. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small, 2009, 5: 701-708.
17. Jiang X M, Wang L M, Chen C Y. Cellular uptake, intracellular trafficking and biological responses of gold nanomaterials. J Chin Chem Soc, 2011, 58: 1-10.
18. Zhao F, Zhao Y, Liu Y, et al. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small, 2011, 7: 1322-1337.
19. Qiu Y, Liu Y, Wang L, et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials, 2010, 31: 7606-7619.
20. Wang L, Liu Y, Li W, et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett, 2011, 11: 772-780.
21. Kelly K L, Coronado E, Zhao L, et al. The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J Phys Chem B, 2003, 107: 668-677.
22. Link S, El-Sayed M A. Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J Phys Chem B, 1999, 103: 8410-8426.
23. Link S, El-Sayed M A. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu Rev Phys Chem, 2003, 54: 331-366.
24. Mulvaney P. Surface plasmon spectroscopy of nanosized metal particles. Langmuir, 1996, 12: 788-800.
25. Lee K S, El-Sayed M A. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B, 2006, 110: 19220-19225.
26. Link S, El-Sayed M A. Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem, 2000, 19: 409-453.
27. Jensen T R, Duval M L, Kelly K L, et al. Nanosphere lithography: effect of the external dielectric medium on the surface plasmon resonance spectrum of a periodic array of silver nanoparticles. J Phys Chem B, 1999, 103: 9846-9853.
28. Jain P K, Eustis S, El-Sayed M A, et al. Plasmon coupling in nanorod assemblies: optical absorption, discrete dipole approximation simulation, and exciton-coupling model. J Phys Chem B, 2006, 110: 18243-18253.
29. Haes A J, Stuart D A, Nie S, et al. Using solution-phase nanoparticles, surface-confined nanoparticle arrays and single nanoparticles as biological sensing platforms. J Fluorescence, 2004, 14: 355-367.
30. Haes A J, Hall W P, Chang L, et al. A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease. Nano Lett, 2004, 4: 1029-1034.
31. Sonnichsen C, Reinhard B, Liphardt J, et al. A molecular ruler based on plasmon coupling of single gold and silver nanoparticles. Nat Biotechnol, 2005, 23: 741-745.
32. Yguerabide J, Yguerabide E E. Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications: I. Theory. Anal Biochem, 1998, 262: 137-156.
33. Jain P K, Lee K S, El-Sayed I H, et al. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B, 2006, 110: 7238-7248.
34. Sokolov K, Follen M, Aaron J, et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res, 2003, 63: 1999-2004.
35. Huang X H, El-Sayed I H, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc, 2006, 128: 2115-2120.
36. Ding H, Yong K T, Roy I, et al. Gold nanorods coated with multilayer polyelectrolyte as contrast agents for multimodal imaging. J Phys Chem C, 2007, 111: 12552-12557.
37. Chanda N, Shukla R, Katti K V, et al. Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging. Nano Lett, 2009, 9: 1798-1805.
38. Bouhelier A, Beversluis M R, Novotny L. Characterization of nanoplasmonic structures by locally excited photoluminescence. Appl Phys Lett, 2003, 83: 5041-5043.
39. Maiorano G, Sabella S, Sorce B, et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano, 2010, 4: 7481-7491.
40. Durr N J, Larson T, Smith D K, et al. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett, 2007, 7: 941-945.
41. Tong L, Zhao Y, Huff T B, et al. Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv Mater, 2007, 19: 3136-3141.
42. Brusnichkin A V, Nedosekin D A, Proskurnin M A, et al. Photothermal lens detection of gold nanoparticles: theory and experiments. Appl Spectrosc, 2007, 61: 1191-1201.
43. Li P C, Wang C R, Shieh D B, et al. In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods. Opt Express, 2008, 16: 18605-18615.
44. Maltzahn G, Park J H, Agrawal A, et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res, 2009, 69: 3892-3900.
45. Dreaden E C, Mackey M A, Huang X H, et al. Beating cancer in multiple ways using nanogold. Chem Soc Rev, 2011, 40: 3391-3404.
46. Cheng L, Yang K, Li Y, et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem Int Ed, 2011, 50: 7385-7390.
47. Cobley C M, Au L, Chen J, et al. Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Expert Opin Drug Delivery, 2010, 7: 577-587.
48. Kennedy L C, Bickford L R, Lewinski N A, et al. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small, 2011, 7: 169-183.
49. Connor E E, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 2005, 1: 325-327.
50. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol, 2001, 19: 316-317.
51. Urbanska K, Romanowska-Dixon B, Matuszak Z, et al. Indocyanine green as a prospective sensitizer for photodynamic therapy of melanomas. Acta Biochim Pol, 2002, 49: 387-391.
52. Katz E, Willner I. Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications. Angew Chem Int Ed, 2004, 43: 6042-6108.
53. Niemeyer C M. Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew Chem Int Ed, 2001, 40: 4128-4158.
54. Pitsillides C M, Joe E K, Wei X, et al. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J, 2003, 84: 4023-4032.
55. Huang X, Jain P K, El-Sayed I H, et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci, 2008, 23: 217-228.
56. El-Sayed I H, Huang X, El-Sayed M A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett, 2006, 239: 129-135.
57. Hirsch L R, Stafford R J, Bankson J A, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA, 2003, 100: 13549-13554.
58. Dickerson E B, Dreaden E C, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett, 2008, 269: 57-66.
59. El-Sayed M A. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res, 2001, 34: 257-264.
60. Gobin A M, Watkins E M, Quevedo E, et al. Near-infrared-resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic Agent. Small, 2010, 6: 745-752.
61. Mulvaney P. Surface plasmon spectroscopy of nanosized metal particles. Langmuir, 1996, 12: 788-800.
62. Norman R S, Stone J W, Gole A, et al. Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett, 2008, 8: 302-306.
63. Hanahan D, Weinberg R A. Hallmarks of cancer: the next generation. Cell, 2011, 144: 646-674.
64. Roa W, Zhang X J, Guo L H, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology, 2009, 20: 375101.
65. Bhattacharya R, Mukherjee P, Xiong Z, et al. Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett, 2004, 4: 2479-2481.
66. Kang B, Mackey M A, El-Sayed M A. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc, 2010, 132: 1517-1519.
67. Mukherjee P, Bhattacharya R, Wang P, et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res, 2005, 11: 3530-3534.
68. Pan Y, Leifert A, Ruau D, et al. Gold nanoparticles of diameter 1. 4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small, 2009, 5: 2067-2076.
69. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 1986, 46: 6387-6392.
70. Zhang Z, Wang L, Wang J, et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater, 2012, 24: 1418-1423.
71. Paciotti G F, Kingston D G, Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev Res, 2006, 67: 47-54.
72. Dreaden E C, Mwakwari S C, Sodji Q H, et al. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjugate Chem, 2009, 20: 2247-2253.
73. Dhar S, Daniel W L, Giljohann D A, et al. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc, 2009, 131: 14652-14653.
74. Brown S D, Nativo P, Smith J A, et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of Oxaliplatin. J Am Chem Soc, 2010, 132: 4678-4684.
75. You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano, 2010, 4: 1033-1041.
76. Gibson J D, Khanal B P, Zubarev E R. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc, 2007, 129: 11653-11661.
77. Chen Y H, Tsai C Y, Huang P Y, et al. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharmaceutics, 2007, 4: 713-722.
78. Cheng Y, Samia A C, Li J, et al. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. Langmuir, 2009, 26: 2248-2255.
79. Xu L, Liu Y, Chen Z, et al. Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment. Nano Lett, 2012, 12: 2003-2012.
80. Li Y, Chen C. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small, 2011, 7: 2965-2980.